N-(2,3-Dimethylphenyl)-4-methylpyrrolidin-2-imine Hydrochloride

ID: ALA3408290

Chembl Id: CHEMBL3408290

PubChem CID: 89964574

Max Phase: Preclinical

Molecular Formula: C13H19ClN2

Molecular Weight: 202.30

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cccc(/N=C2\CC(C)CN2)c1C.Cl

Standard InChI:  InChI=1S/C13H18N2.ClH/c1-9-7-13(14-8-9)15-12-6-4-5-10(2)11(12)3;/h4-6,9H,7-8H2,1-3H3,(H,14,15);1H

Standard InChI Key:  RXYHPPZJPWYRFF-UHFFFAOYSA-N

Associated Targets(Human)

ADRA2A Tclin Adrenergic receptor alpha-2 (812 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nisch Nischarin (241 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 202.30Molecular Weight (Monoisotopic): 202.1470AlogP: 2.96#Rotatable Bonds: 1
Polar Surface Area: 24.39Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 9.80CX LogP: 2.99CX LogD: 1.29
Aromatic Rings: 1Heavy Atoms: 15QED Weighted: 0.74Np Likeness Score: -0.52

References

1. Gasparik V, Greney H, Schann S, Feldman J, Fellmann L, Ehrhardt JD, Bousquet P..  (2015)  Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.,  58  (2): [PMID:25521963] [10.1021/jm501456p]

Source